@article{eee7272026ba427d9b9e422444f15ac1,
title = "Guidelines for acromegaly management: An update",
abstract = "Objective: The Acromegaly Consensus Group reconvened in November 2007 to update guidelines for acromegaly management. Participants: The meeting participants comprised 68 pituitary specialists, including neurosurgeons and endocrinologists with extensive experience treating patients with acromegaly. Evidence/Consensus Process: Goals of treatment and the appropriate imaging and biochemical and clinical monitoring of patients with acromegaly were enunciated, based on the available published evidence. Conclusions: The group developed a consensus on the approach to managing acromegaly including appropriate roles for neurosurgery, medical therapy, and radiation therapy in the management of these patients.",
author = "S. Melmed and A. Colao and A. Barkan and M. Molitch and Grossman, {A. B.} and D. Kleinberg and D. Clemmons and P. Chanson and E. Laws and J. Schlechte and Vance, {M. L.} and K. Ho and A. Giustina",
note = "Funding Information: This study was sponsored by the Pituitary Society and the European Neuroendocrine Association and was supported by unrestricted grants from Ipsen and Tercica, Inc. Editorial assistance was provided by ESP BioScience. Funding Information: Disclosure Summary: A.C., D.C., E.L., J.S., and M.L.V. have nothing to declare. A.B. has consulted for Ipsen. M.M. has received research grants from Tercica and Ipsen and has consulted, received honoraria, and been a spokesperson for Tercica. A.B.G. has consulted for, served on advisory boards for, received honoraria from, and been a spokesperson for Ipsen and Novartis. D.K. has consulted for, served on advisory boards for, and received honoraria from Ipsen. P.C. has served on advisory boards for Novartis and has received honoraria from Novartis, Ipsen, and Pfizer. K.H. has consulted for Novartis and Ipsen. S.M. has consulted for Novartis and Ipsen and received a grant from Novartis. A.G. has consulted for Ipsen, Pfizer, and Italfarmaco and has received lecture fees from Novartis and Italfarmaco. ",
year = "2009",
month = may,
doi = "10.1210/jc.2008-2421",
language = "English (US)",
volume = "94",
pages = "1509--1517",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",
}